The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Treatment- naïve people living with HIV now have drug-sparing antiretroviral treatment options with new once-daily, two-drug, fixed-dose treatment, Dovato.
HIV care attrition is more common in paediatric patients living with HIV; understanding how much of this is mortality-related can help policymakers develop interventions to stop it.
Cost should not be a barrier for the full implementation of cryptococcal meningitis screening programmes for people living with HIV as per World Health Organization recommendations.
New research reveals that, like adults, young people have better treatment outcomes with a lower pill burden.
Populations considered hard to treat or engage in care can benefit from same-day antiretroviral treatment as part of a clinic offering social safety-net interventions.
Multiple partners, migration, and living in an HIV ‘hotspot’ have been identified as key drivers of unsuppressed viral load among young women living with HIV in KwaZulu-Natal, South Africa.
New research reveals high rates of loss to follow-up among adolescents, with rates among those acquiring the infection in their teens nearly three times that of those infected perinatally.
The type of relationship someone living with HIV has with both their social network and a nominated ‘treatment partner’ is likely to influence whether they are virally suppressed, research from Botswana suggests.
New data on the impact of different treatment strategies on the neuro-development of young children living with HIV has been released, showing normal development in all areas apart from visual perception.
Researchers recommend dolutegravir (DTG)‐based antiretrovirals should become the first option for HIV treatment in India, following a study into DTG’s cost-effectiveness.